Prelim nod for SkyePharma/Kyorin's Flutiform in Japan
This article was originally published in Scrip
Executive Summary
Following a regulatory submission in September last year, SkyePharma's combination respiratory product Flutiform has been recommended for approval in Japan, for the treatment of bronchial asthma.